K222116: Atellica® CI Analyzer, Atellica® IMThyroid Stimulating Hormone 3-Ultra (TSH3-UL), Atellica® CH Albumin BCP (AlbP) (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K222116 (Atellica® CI Analyzer, Atellica® IMThyroid Stimulating Hormone 3-Ultra (TSH3-UL), Atellica® CH Albumin BCP (AlbP), cleared 2023-07-13 for Siemens Healthcare Diagnostics, Inc.) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K222116
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK222116
Cleared Device Trade / Generic NameAtellica® CI Analyzer, Atellica® IMThyroid Stimulating Hormone 3-Ultra (TSH3-UL), Atellica® CH Albumin BCP (AlbP)
FDA Applicant on FilingSiemens Healthcare Diagnostics, Inc.
FDA 3-Letter Product ClassificationProduct Code JLW
FDA Substantial Equivalence Decision Date2023-07-13
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Siemens Healthineers across sibling Meru public-data platforms.

Inspect consolidated manufacturer lineage at Siemens Healthcare Diagnostics, Inc., compare peer devices under FDA Product Code JLW, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.